Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aluminum hydroxide (Gaviscon) (1 trial)
Emphysema (Phase 2)
Lung Diseases (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Pulmonary Emphysema (Phase 2)
Trials (1 total)
Trial APIs (1 total)